Inactive Instrument

Press Releases OTR ACQU

Equities

OTRA

US67113Q1058

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

OTR ACQU : Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics - Form 8-K	24/05/22	PU
Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics	20/05/22	BU
OTR ACQUISITION CORP. : Other Events (form 8-K)	18/05/22	AQ
OTR ACQUISITION CORP. : Other Events (form 8-K)	16/05/22	AQ
OTR ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13/05/22	AQ
OTR ACQUISITION CORP. Submission of Matters to a Vote of Security Holders, Other Events (form 8-K/A)	13/05/22	AQ
OTR ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)	12/05/22	AQ
Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation	09/05/22	BU
Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo	27/04/22	BU
Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration	19/04/22	BU
Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination	18/04/22	BU
OTR ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	08/03/22	AQ
OTR ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	02/03/22	AQ
OTR Acquisition : Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination - Form 8-K	04/02/22	PU
OTR ACQUISITION CORP. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	04/02/22	AQ
OTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination	04/02/22	BU
OTR Acquisition : Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp - Form 8-K	31/01/22	PU
OTR ACQUISITION CORP. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	31/01/22	AQ
Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.	31/01/22	BU
OTR ACQUISITION CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	30/11/21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases OTR ACQU

Equities

OTRA

US67113Q1058

Press Releases

Filters